Breast cancer (BC) is the most prevalent and fatal cancer affecting women worldwide [1], however we still lack sufficient tools to detect and halt its progression at an early stage. Approximately 80% of BC cases are hormone-responsive BC, characterized by estrogen receptor (ER) expression in BC cells....
Breast cancer stands as the most prevalent form of cancer among women and the primary cause of cancer-related mortality in women, with its burden anticipated to rise consistently [1, 2]. Notably, metabolic risks, such as an elevated body mass index (BMI) and heightened fasting glucose levels, are significant...
Breast cancer (BC) is the most prevalent cancer globally, accounting for 11.7% of all cancer cases, with approximately 2.3 million new cases and 685,000 deaths reported worldwide in 2020 [1]. In Italy BC is the most frequently diagnosed cancer among women, with an estimated 55,900 new cases in 2023...
Radiotherapy following breast-conserving surgery for early-stage breast cancer may enhance locoregional control, diminish the risk of tumor recurrence, and extend survival [1]. However, the potential for inadequate dosing to the targeted breast area and increased doses of normal tissues is a consequence...